Use of PPAR agonists for the treatment of congestive heart failure

Details for Australian Patent Application No. 2005315920 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Schaefer, Hans-Ludwig; Schafer, Stefan; Falk, Eugen; Linz, Wolfgang

Agent Watermark

Pub. Number AU-A-2005315920

PCT Pub. Number WO2006/063715

Priority 04029946.3 17.12.04 EP

Filing date 6 December 2005

Wipo publication date 22 June 2006

International Classifications

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/063715 Priority application(s): WO2006/063715

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315921-Compositions comprising extracts from Sanguinaria or Macleaya

2005315919-Pharmaceutical compositions for the treatment of cellulite